ABC News correspondent Will Reeve has revealed he was diagnosed with testicular cancer in April, undergoing multiple surgeries and chemotherapy treatments. The New York-based correspondent, who reports for platforms including Good Morning America, shared his story publicly on Tuesday.

Reeve, 34, stated that his wife, Amanda, encouraged him to seek medical attention in April after he discovered a lump in his left testicle. This discovery led to an ultrasound that identified a mass, prompting an orchiectomy, a procedure to remove the testicle, in early May. The subsequent analysis confirmed a diagnosis of embryonal carcinoma, an aggressive form of testicular cancer.

Following the initial surgery, Reeve underwent a second procedure in June, a retroperitoneal lymph node dissection, to remove numerous lymph nodes. Because some of these removed lymph nodes contained cancerous cells, Reeve opted for two cycles of chemotherapy to significantly reduce the risk of the cancer's recurrence. He began chemotherapy in early July, with his wife by his side during treatment sessions at Memorial Sloan Kettering Cancer Center in New York City.

Reeve's chemotherapy treatment involved two hours of infusion and seven hours of cold capping, a method used to minimize hair loss. He experienced side effects such as bone pain, tinnitus, night sweats, blood clots, and headaches during the recovery period between treatments. By the end of July, Reeve successfully completed his chemotherapy regimen and marked the occasion by ringing the bell at Sloan Kettering, a symbol of the end of treatment.

In sharing his personal health battle, Reeve expressed a desire to raise awareness about testicular cancer. He emphasized that while the diagnosis can be shocking and awkward to discuss, outcomes are often positive. He noted that his mother, Dana Reeve, also underwent chemotherapy at Sloan Kettering before her death from lung cancer at age 44 in 2006.

Reeve's journey involved significant medical interventions, including the removal of his testicle and dozens of lymph nodes, followed by chemotherapy. The aggressive nature of embryonal carcinoma, often found in younger to middle-aged individuals, underscored the urgency of his treatment.

His decision to undergo chemotherapy was aimed at lowering the odds of the cancer returning to approximately 1%. The extensive treatment involved sitting for hours at the cancer center, supported by his wife.

Further details about Reeve's experience, including insights from a doctor and other cancer patients, are expected to be featured on Good Morning America on Wednesday and Thursday.